BRAIN Biotech AG

Research BRAIN Biotech AG (BNN) on Bullrun: market cap EUR 61.17M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerBNN
• ExchangeXETRA
• CountryGermany
• SectorBasic Materials
• IndustrySpecialty Chemicals
• CurrencyEUR
• Market capEUR 61.17M
• Financial periodQ4 2025
• RevenueEUR 11.92M
• Net income-EUR 2.91M
• Free cash flow-EUR 2.06M
• Gross margin62.1%

Valuation Snapshot

latest market cap is EUR 61.17M.

About BRAIN Biotech AG

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator. The BRAINBiocatalysts segment develops, produces, and distributes specialty enzymes, microorganisms, and ingredients. The BRAINBioIncubator segment encompasses a pipeline of research-intensive development projects primarily for the life sciences industry.

Frequently asked questions

What is BRAIN Biotech AG's market cap?

BRAIN Biotech AG's market capitalization is EUR 61.17M.

What does BRAIN Biotech AG do?

BRAIN Biotech AG provides bio-based products and solutions in Germany, the United States, France, the Netherlands, and the United Kingdom. The company operates through two segments: BRAINBiocatalysts and BRAINBioIncubator.